• What is a trade secret?
• Interim & final remedies
• Eight mandatory requirements for seizure
• Seizure Denials
• Granted Seizures
• The Inevitable Disclosure Doctrine
• Case Study - UTSA v. Common Law (New York) - Yellowfin Yachts v. Barker Boatworks, LLC - Abrasic 90 Inc. v. Weldcote - Compulife Software, Inc. v. Newman, 2020 - Waymo v. Uber - BioTech Trade Secrets v. Patents - Agilent v. Twist
Runtime: 1 hour, 31 minutes Recorded: March 31, 2021
This program will explain trade secrets, how they work, and how they are maintained and enforced. Attendees will learn about key issues that have emerged under trade secret law, such as the inevitable disclosure doctrine and its status under federal law, why trade secret law has become increasingly important, particularly given SCOTUS decisions regarding patentability of biotech and life science IP, interim remedies and kinds of damages available in trade secret litigation, and how the federal trade secret statute can be enforced overseas.
This program will examine the basics of CDA 230 and its day to day affect for those who advise internet businesses as well as those who litigate against them. It will give practical guidance as to what extend internet companies can or should edit or censor the information their users contribute to their sites and to what extent those users will actually be liable.
This panel of lawyers and insolvency professionals with bankruptcy expertise will lead a roundtable discussion regarding investigation of debtors and recovering assets to enhance the value of a bankruptcy estate.